Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Change in Account Payables (2016 - 2026)

Crescent Biopharma (CBIO) has disclosed Change in Account Payables for 12 consecutive years, with -$2.3 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Account Payables fell 546.33% year-over-year to -$2.3 million; the TTM value through Mar 2026 reached -$1.7 million, down 168.6%, while the annual FY2025 figure was $2.1 million, 486.22% up from the prior year.
  • Change in Account Payables hit -$2.3 million in Q1 2026 for Crescent Biopharma, down from $1.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.6 million in Q3 2024 and bottomed at -$2.3 million in Q1 2026.
  • Average Change in Account Payables over 5 years is -$107791.5, with a median of -$12091.5 recorded in 2023.
  • Year-over-year, Change in Account Payables skyrocketed 1667.01% in 2024 and then crashed 546.33% in 2026.
  • Crescent Biopharma's Change in Account Payables stood at $118066.0 in 2022, then skyrocketed by 355.87% to $538230.0 in 2023, then skyrocketed by 190.21% to $1.6 million in 2024, then crashed by 34.44% to $1.0 million in 2025, then plummeted by 325.78% to -$2.3 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$2.3 million, $1.0 million, and -$949000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.